SpringWorks Therapeutics: Promising Launches, Expanding Pipeline, And M&A Buzz
SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...
Stocktwits on MSN1 天
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling ...
SpringWorks Therapeutics (SWTX) saw the biggest retail follower increase among biotech stocks last week on Stocktwits, even ...
Investors Buy Large Volume of SpringWorks Therapeutics Call Options (NASDAQ:SWTX)
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) saw some unusual options trading on Thursday. Traders acquired 13,068 call options on the stock. This is an increase of 223% compared to ...
Check Out What Whales Are Doing With SWTX
Our analysis of options history for SpringWorks Therapeutics SWTX revealed 9 unusual trades. Delving into the details, we ...
【德国默克就收购美国生物技术公司 Spr
【德国默克就收购美国生物技术公司 SpringWorks 进行深入谈判】德国医疗保健和技术集团默克公司周一表示，该公司正在 就收购美国癌症和罕见病制药商SpringWorks Therapeutics进行深入谈判。默克公司在声明中说，收购SpringWorks的谈判正在进行中。这家总部位于德国达姆施塔特（Darmstadt）的公司表示，尚未签署任何具有法律约束力的协议，也不确定交易是否会实现。
Merck KGaA reports YE24 earnings growth amid SpringWorks acquisition talks
While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.
Mesothelioma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action ...
DelveInsight’s, “Mesothelioma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 50+ ...
Merck KGaA says ‘no certainty’ SpringWorks deal will be signed
On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics ( SWTX ), Inc., USA. At the time of the preparation of the Consolidated ...
SpringWorks cancelled from conference this week, says Barclays
Barclays analyst Peter Lawson says SpringWorks Therapeutics (SWTX) this morning cancelled from the firm’s conference next week, following ...
Endpoints News5 天
No news is good news? Mer­ck KGaA qui­et on po­ten­tial Spring­Works takeover
Ahead of Merck KGaA’s earnings announcement Thursday, investors were mostly looking forward to any comments about its ...
Oppenheimer Asset Management Inc. Cuts Stock Position in SpringWorks Therapeutics, Inc ...
Oppenheimer Asset Management Inc. lessened its stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) by 6.2% in ...
SpringWorks Therapeutics首席运营官出售价值108万美元普通股
根据监管文件显示，SpringWorks Therapeutics, Inc.（NASDAQ:SWTX）首席运营官Edris Badreddin于2025年3月3日出售了大量公司普通股。Badreddin以每股53.12美元至56.20美元的价格出售了20,000股，交易总额约为1,084,592美元。在SWTX过去六个月股价上涨26%且保持93%高毛利率的强劲势头下完成了此次交易。根据 ...